These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18525350)

  • 1. The interleukin-23/interleukin-17 axis in spondyloarthritis.
    Layh-Schmitt G; Colbert RA
    Curr Opin Rheumatol; 2008 Jul; 20(4):392-7. PubMed ID: 18525350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis.
    Coffre M; Roumier M; Rybczynska M; Sechet E; Law HK; Gossec L; Dougados M; Bianchi E; Rogge L
    Arthritis Rheum; 2013 Jun; 65(6):1510-21. PubMed ID: 23508476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
    Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
    Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats.
    DeLay ML; Turner MJ; Klenk EI; Smith JA; Sowders DP; Colbert RA
    Arthritis Rheum; 2009 Sep; 60(9):2633-43. PubMed ID: 19714651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From HLA-B27 to spondyloarthritis: a journey through the ER.
    Colbert RA; DeLay ML; Klenk EI; Layh-Schmitt G
    Immunol Rev; 2010 Jan; 233(1):181-202. PubMed ID: 20193000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis.
    Cauli A; Mathieu A
    J Rheumatol Suppl; 2012 Jul; 89():15-8. PubMed ID: 22751583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort.
    Poddubnyy DA; Märker-Hermann E; Kaluza-Schilling W; Zeidler H; Braun J; Listing J; Sieper J; Rudwaleit M
    J Rheumatol; 2011 Nov; 38(11):2436-41. PubMed ID: 21885496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
    Bowness P; Ridley A; Shaw J; Chan AT; Wong-Baeza I; Fleming M; Cummings F; McMichael A; Kollnberger S
    J Immunol; 2011 Feb; 186(4):2672-80. PubMed ID: 21248258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
    Raychaudhuri SK; Saxena A; Raychaudhuri SP
    Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 misfolding and spondyloarthropathies.
    Colbert RA; DeLay ML; Layh-Schmitt G; Sowders DP
    Adv Exp Med Biol; 2009; 649():217-34. PubMed ID: 19731632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived dendritic cells from HLA-B27+ axial spondyloarthritis (SpA) patients display altered functional capacity and deregulated gene expression.
    Talpin A; Costantino F; Bonilla N; Leboime A; Letourneur F; Jacques S; Dumont F; Amraoui S; Dutertre CA; Garchon HJ; Breban M; Chiocchia G
    Arthritis Res Ther; 2014 Aug; 16(4):417. PubMed ID: 25142923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Inter-omic Analysis Reveals Relationships Between Diverse Gut Microbiota and Host Immune Dysregulation in HLA-B27-Induced Experimental Spondyloarthritis.
    Gill T; Brooks SR; Rosenbaum JT; Asquith M; Colbert RA
    Arthritis Rheumatol; 2019 Nov; 71(11):1849-1857. PubMed ID: 31216122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of HLA-B27 on Gut Microbiota in Experimental Spondyloarthritis Implicate an Ecological Model of Dysbiosis.
    Gill T; Asquith M; Brooks SR; Rosenbaum JT; Colbert RA
    Arthritis Rheumatol; 2018 Apr; 70(4):555-565. PubMed ID: 29287307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.
    Bautista-Caro MB; Arroyo-Villa I; Castillo-Gallego C; de Miguel E; Peiteado D; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    Rheumatology (Oxford); 2013 Feb; 52(2):352-62. PubMed ID: 23065314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
    Bridgewood C; Sharif K; Sherlock J; Watad A; McGonagle D
    Immunol Rev; 2020 Mar; 294(1):27-47. PubMed ID: 31957051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B27 and pathogenesis of spondyloarthropathies.
    Turner MJ; Colbert RA
    Curr Opin Rheumatol; 2002 Jul; 14(4):367-72. PubMed ID: 12118169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative Pathobionts in HLA-B27-Associated Spondyloarthropathy.
    Gill T; Rosenbaum JT
    Front Immunol; 2020; 11():586494. PubMed ID: 33537028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B27 misfolding and ankylosing spondylitis.
    Colbert RA; Tran TM; Layh-Schmitt G
    Mol Immunol; 2014 Jan; 57(1):44-51. PubMed ID: 23993278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses.
    Jouhault Q; Cherqaoui B; Jobart-Malfait A; Glatigny S; Lauraine M; Hulot A; Morelle G; Hagege B; Ermoza K; El Marjou A; Izac B; Saintpierre B; Letourneur F; Rémy S; Anegon I; Boissier MC; Chiocchia G; Breban M; Araujo LM
    Front Immunol; 2022; 13():1072420. PubMed ID: 36818477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.